EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

TROP2 Expression and Therapeutic Implications in Cutaneous Squamous Cell Carcinoma: Insights From Immunohistochemical and Functional Analysis

Keiko Tanegashima, Yuka Tanaka, Takamichi Ito, Yoshinao Oda, Takeshi Nakahara

Experimental Dermatology · 2024-10 · 33 (10)

DOI: 10.1111/exd.15196 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Dermatology, online erschienen am 18.10.2024. Verfasst von Keiko Tanegashima und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Skin Neoplasms, Carcinoma, Squamous Cell, Antigens, Neoplasm, Cell Adhesion Molecules. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous squamous cell carcinoma (cSCC) is a common form of skin cancer, but treatments for advanced cases have limited efficacy. Trophoblast cell‐surface antigen 2 (TROP2) is a cell‐surface protein that is widely expressed in various tumours, where it exerts significant influence over critical processes such as tumour cell growth, apoptosis, migration, invasion and metastasis. Sacituzumab govitecan, an antibody‐drug conjugate (ADC) targeting TROP2, is emerging as a promising strategy for anticancer therapy. In this study, we investigated TROP2 expression in cSCC tissues from 51 patients and evaluated its function in the A431 human SCC cell line. Immunohistochemical analysis revealed TROP2 expression on the plasma membrane of cSCC tissues and A431 cells. A431 cells showed sensitivity to sacituzumab govitecan with a significant concentration‐dependent decrease in viable cell number. In addition, Knockdown of TROP2 resulted in decreased expression of cyclin D1 and BCL‐2, along with reduced cell viability. Knockdown of TROP2 also resulted in decreased expression of vimentin, along with reduced migratory capacity. These findings suggest that TROP2 plays a crucial role in cSCC cell proliferation and migration, and highlight the potential of sacituzumab govitecan as a promising therapeutic option for cSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsCarcinoma, Squamous CellAntigens, NeoplasmCell Adhesion MoleculesAntibodies, Monoclonal, HumanizedCell MovementHumansCell Line, TumorCell SurvivalImmunohistochemistryImmunoconjugatesFemaleGene Knockdown TechniquesCyclin D1VimentinProto-Oncogene Proteins c-bcl-2AgedCell ProliferationMiddle AgedMaleApoptosisCamptothecin

Stichwörter der Autor:innen

antibody‐drug conjugatecutaneous squamous cell carcinomatargeted therapytrophoblast cell‐surface antigen 2

Substanzen

TACSTD2 protein, humanAntigens, NeoplasmCell Adhesion MoleculesAntibodies, Monoclonal, Humanizedsacituzumab govitecanImmunoconjugatesCyclin D1VimentinProto-Oncogene Proteins c-bcl-2Camptothecin

Autor:innen und Institutionen

  • Department of Dermatology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Tanegashima, K., Tanaka, Y., Ito, T., Oda, Y., & Nakahara, T. (2024). TROP2 Expression and Therapeutic Implications in Cutaneous Squamous Cell Carcinoma: Insights From Immunohistochemical and Functional Analysis. Experimental Dermatology, 33(10). https://doi.org/10.1111/exd.15196

Vancouver

Tanegashima K, Tanaka Y, Ito T, Oda Y, Nakahara T. TROP2 Expression and Therapeutic Implications in Cutaneous Squamous Cell Carcinoma: Insights From Immunohistochemical and Functional Analysis. Experimental Dermatology. 2024;33(10). doi:10.1111/exd.15196

BibTeX
@article{Tanegashima2024,
  author = {Tanegashima, Keiko and Tanaka, Yuka and Ito, Takamichi and Oda, Yoshinao and Nakahara, Takeshi},
  title = {TROP2 Expression and Therapeutic Implications in Cutaneous Squamous Cell Carcinoma: Insights From Immunohistochemical and Functional Analysis},
  journal = {Experimental Dermatology},
  year = {2024},
  volume = {33},
  number = {10},
  doi = {10.1111/exd.15196}
}
Kostenlos starten →